Key Financial Data Of Reporting Company

SymBio Pharmaceuticals Limited - Filing #7272884

Concept As at
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
As at
2024-12-31
As at
2024-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
As at
2022-12-31
2022-01-01 to
2022-12-31
As at
2022-12-31
2022-01-01 to
2022-12-31
2021-01-01 to
2021-12-31
As at
2021-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
2020-01-01 to
2020-12-31
As at
2020-12-31
2020-01-01 to
2020-12-31
As at
2020-12-31
Key financial data of reporting company
Business results of reporting company
Net sales
2,452,912,000 JPY
2,452,912,000 JPY
5,589,708,000 JPY
5,589,708,000 JPY
10,008,338,000 JPY
10,008,338,000 JPY
8,256,924,000 JPY
JPY
JPY
2,987,051,000 JPY
Ordinary profit (loss)
-3,802,316,000 JPY
-3,689,435,000 JPY
-736,130,000 JPY
-773,822,000 JPY
1,999,878,000 JPY
2,001,204,000 JPY
1,001,133,000 JPY
JPY
JPY
-4,615,903,000 JPY
Profit (loss)
-3,923,638,000 JPY
-1,986,723,000 JPY
1,186,022,000 JPY
2,032,203,000 JPY
-4,090,216,000 JPY
Equity in earnings (losses) of affiliates if equity method is applied
JPY
JPY
JPY
JPY
JPY
Share capital
18,336,841,000 JPY
17,952,692,000 JPY
17,548,459,000 JPY
17,157,628,000 JPY
17,044,943,000 JPY
Total number of issued shares
45,928,856 xbrli:shares
42,278,081 xbrli:shares
39,603,606 xbrli:shares
38,457,206 xbrli:shares
38,202,956 xbrli:shares
Net assets
4,080,779,000 JPY
4,197,560,000 JPY
7,209,909,000 JPY
7,197,165,000 JPY
8,506,092,000 JPY
8,511,025,000 JPY
6,745,672,000 JPY
JPY
4,657,318,000 JPY
JPY
Total assets
4,719,369,000 JPY
4,968,333,000 JPY
8,170,243,000 JPY
8,177,010,000 JPY
10,433,347,000 JPY
10,410,354,000 JPY
8,452,997,000 JPY
JPY
6,274,707,000 JPY
JPY
Net assets per share
82.12
84.66
164.32
164.02
204.83
204.95
162.26
105.76
Dividend paid per share
Interim dividend paid per share
Basic earnings (loss) per share
-87.00
-85.00
-49.19
-49.79
30.20
30.37
53.04
-124.13
Diluted earnings per share
29.77
29.95
52.32
Equity-to-asset ratio
0.797 xbrli:pure
0.781 xbrli:pure
0.849 xbrli:pure
0.846 xbrli:pure
0.776 xbrli:pure
0.778 xbrli:pure
0.737 xbrli:pure
xbrli:pure
0.643 xbrli:pure
xbrli:pure
Rate of return on equity
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
0.146 xbrli:pure
0.166 xbrli:pure
0.396 xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
Price-earnings ratio
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
21.3 xbrli:pure
21.2 xbrli:pure
21.6 xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
Payout ratio
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
Net cash provided by (used in) operating activities
JPY
-3,416,518,000 JPY
-194,685,000 JPY
JPY
1,614,241,000 JPY
JPY
140,042,000 JPY
JPY
JPY
-4,122,483,000 JPY
Net cash provided by (used in) investing activities
JPY
-3,955,000 JPY
-376,696,000 JPY
JPY
-47,127,000 JPY
JPY
-70,849,000 JPY
JPY
JPY
-160,309,000 JPY
Net cash provided by (used in) financing activities
JPY
708,472,000 JPY
680,160,000 JPY
JPY
627,985,000 JPY
JPY
-71,922,000 JPY
JPY
JPY
4,222,090,000 JPY
Cash and cash equivalents
JPY
3,963,580,000 JPY
6,517,007,000 JPY
JPY
6,282,554,000 JPY
JPY
3,860,106,000 JPY
JPY
3,848,626,000 JPY
JPY
Number of employees
101 xbrli:pure
108 xbrli:pure
108 xbrli:pure
109 xbrli:pure
103 xbrli:pure
122 xbrli:pure
118 xbrli:pure
141 xbrli:pure
xbrli:pure
127 xbrli:pure
xbrli:pure
Average number of temporary employees
15 xbrli:pure
15 xbrli:pure
15 xbrli:pure
20 xbrli:pure
20 xbrli:pure
30 xbrli:pure
28 xbrli:pure
45 xbrli:pure
xbrli:pure
41 xbrli:pure
xbrli:pure
Total shareholder return
0.328 xbrli:pure
0.407 xbrli:pure
1.059 xbrli:pure
1.886 xbrli:pure
0.624 xbrli:pure
Total return on share price index
1.825 xbrli:pure
1.515 xbrli:pure
1.181 xbrli:pure
1.211 xbrli:pure
1.074 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.